Clinical Trial Update: PROSTVAC in Combination With Nivolumab in Men With Prostate Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating PROSTVAC-VF in combination with nivolumab in men with prostate cancer has completed, with results posted on May 31, 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• PROSTVAC-VF (PROSTVAC-VF)
• nivolumab (nivolumab)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Prostate Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-05-31